
SNSF Ambizione Group Leader @unil Passionate about reprogramming, aging,hematology and immunology Postdoc at @OcampoLab //Ph.D. Student at @MMittelbrunn's lab
Joined March 2020
- Tweets845
- Following939
- Followers819
- Likes4.2K
Gabi Desdín retweeted
🔬 ¡Prácticas remuneradas en el Caravia Lab!
Buscamos estudiantes de Máster Oficial interesados en cardiología molecular y edición genómica en el IBBTEC, Santander.
📌 6 semanas | 💶 500 €/mes
📄 CV + carta + expediente ≥8
📩 [email protected]
¡Se agradece difusión! 🙌
Gabi Desdín retweeted
🚨 New paper from @MMittelbrunn Lab @CBM_CSIC_UAM
We show that butyrate extends health and lifespan in mouse models of mitochondrial disease — highlighting a powerful link between mitochondrial dysfunction and the gut microbiota
🔗 Read the paper here: doi.org/10.1038/s41467-026-7…
Gabi Desdín retweeted
4/5 The result that surprised me most:
The genetic interaction networks in males and females are almost completely separate 🤯.
78 epistatic links in males, 72 in females. Only 2 overlap.
If you ignore sex in aging genetics, you get the wrong answer. Full stop.
Gabi Desdín retweeted
Totally agree. Academia should stop endorsing this behaviour by top (and smt non so top) journals. Is not fair to spent 2-3 years under review...many times to end up in a rejection after weird journal behaviours. They simply play with potsdocs' life's to earn massive revenues.
This paper took nearly 3 years to be published from the time of submission.
Meanwhile, many academics still don’t consider work real if it appears first as a preprint.
That means years of additional resources were spent satisfying peer review, endless postdoc and student hours chasing incremental revisions.
The core results were likely known 5–7 years ago.
And if there had been even a small hiccup along the way, it likely would have landed in a lower-tier Nature branded journal such as Nature Communications and received none of the attention or breakthrough framing.
This system needs to change. Funding agencies should not just stop paying publishers, but require institutions that take their money not to subscribe to them. Limits on how much grant funding can be spent on endless revisions should be in place too.
Gabi Desdín retweeted
Just uploaded to @biorxivpreprint. Our latest preprint from @ColladoLab:
“Extracellular Vesicles from Senescent Tumor Cells Are Necessary and Sufficient to Drive Paracrine Senescence”
biorxiv.org/content/10.64898…
By @Exosomita and co-supervised by Sabela Da Silva and myself
Gabi Desdín retweeted
📢 Happy to share our work published in @NatureComms
We show that strategies to preserve microbiota-derived butyrate delay multiorgan failure and prolong lifespan in mice with mitochondrial disease, linked to epigenetic remodeling
🔋💪🏼 @EnriqueGab
nature.com/articles/s41467-0…
Gabi Desdín retweeted
Very happy to share our latest publication. I want to specially thank the amazing @mmgomezheras (we'll miss you so much) and @MMittelbrunn
📢 Happy to share our work published in @NatureComms
We show that strategies to preserve microbiota-derived butyrate delay multiorgan failure and prolong lifespan in mice with mitochondrial disease, linked to epigenetic remodeling
🔋💪🏼 @EnriqueGab
nature.com/articles/s41467-0…
Gabi Desdín retweeted
📢The @EpiAgeing_lab is offering an international #PhD contract to carry out a doctoral thesis in #Epitranscriptomics, #earlydevelopment and #cancer, funded by #MaríaDeMaeztu excellence program at @CIMUS/USC (Spain).
🗓️Deadline: 19/04/2026
📌More info:cimus.usc.gal/es/training/md…
Gabi Desdín retweeted
Interested in learning the art of peer review? 📝
@zoltan_ungvari, Editor-in-Chief of GeroScience, invites trainees and mentors to join the journal’s Peer Review Training Program.
For more details, reach out to program director @MattYousefzadeh or visit:
americanagingassociation.org…
Gabi Desdín retweeted
📣Oferta de trabajo en el CBM!
El grupo de María Mittelbrunn @MMittelbrunn busca candidatos para un contrato predoctoral en la MSCA UNION Network (UnderstandiNg fraIlty tOwards a future of healthy ageiNg).
📅Fecha límite: 5 mayo
ℹ️[email protected]
cbm.uam.es/index.php/job/imm…
Gabi Desdín retweeted
📢 Open position: Lab technician 📢 within the project PID2024-156818NB-I00 led by Dr. Rafael Medina & Dr. Elisa Carrasco, funded by @AgEInves . Spread the word! Applications welcome
Gabi Desdín retweeted
We just uploaded our most recent paper to
@biorxivpreprint and submitted the manuscript for publication. We are really excited with this collaboration between our lab @ColladoLab @cimususc and the lab of @HanLi_Pasteur @institutpasteur:
biorxiv.org/content/10.64898…
Gabi Desdín retweeted
2026 is here! We’re excited to share Global Immunotalks first semester poster, featuring an outstanding lineup!
Please share and help us spread the word!
Gabi Desdín retweeted
Online now!✨RESEARCH: Eskiocak et al identify uPAR+ cells as key targets of intestinal aging, and show that elimination with senolytic CAR T cells prevents and restores features of intestinal aging @CSHL nature.com/articles/s43587-0… rdcu.be/eRTeL
Gabi Desdín retweeted
Hey, any #ALS researchers want to get together for a basic biology consortium (TALS has open proposals)?
DM me if so - happy to do a bunch of cool stuff in our organoids!
Gabi Desdín retweeted
Alyssa Tapley was 13 when doctors told her she was going to die.
She was diagnosed with a rare form of leukemia and had endured a year of failed treatments, including chemotherapy and a bone marrow transplant, when her doctors said they had run out of options. They were talking about end-of-life care when Tapley begged them not to give up on her. cbsn.ws/4r5E0EO
Gabi Desdín retweeted
‼️Lymphatic Education&Research Network-GRC Scholarships‼️
LE&RN is awarding 10 × $1,000 scholarships to early investigators to attend 2026 Lymphatics GRC March 1 – March 6, 2026, Lucca (Barga), Italy.
🗓 Apply by Dec 8, 2025!
form.jotform.com/LERN/2026-g…
Gabi Desdín retweeted
Looks like @hevolution_f is not funding anything (GRO, postdoc, etc.) from the 2024 cycle?
Gabi Desdín retweeted
A year ago, Adelina applied to our lab through the VIDA call — a stellar Medical Oncologist with no bench experience. As a small lab, we had to say no.
The next day she came back with an idea: apply for the ESMO Fellowship (deadline in 3 days!).
Yesterday she received her award.
Gabi Desdín retweeted
Great opportunities in Miguel’s lab…….




























